Jiangsu Hengrui Medicine Co., Ltd
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1970-01-01
- Employees
- -
- Market Cap
- $38.9B
A Study to Evaluate SHR-1210 in Subjects With Advanced HCC
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 220
- Registration Number
- NCT02989922
- Locations
- 🇨🇳
Haerbin Medical University Cancer Hospital, Haerbin, Heilongjiang, China
🇨🇳Zhangshan Hospital Fudan University, Shanghai, Shanghai, China
🇨🇳Xiangya Hospital Central South University, Changsha, Hunan, China
A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 279
- Registration Number
- NCT02973737
- Locations
- 🇨🇳
307 Hospital Affiliated to Academy Military Medical Science, Beijing, China
Phase I Study of SHR7390 in Patients With Advanced Solid Tumors
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02968485
- Locations
- 🇨🇳
The Cancer Center,Sun Yat-sen University, Guangzhou, Guangdong, China
Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2016-09-08
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT02892370
- Locations
- 🇨🇳
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
Multiple Dose Study of SHR4640 in Healthy Subjects
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02890966
- Locations
- 🇨🇳
The South West Hospital, Chongqing, Chongqing, China
The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT02868814
- Locations
- 🇨🇳
Xiehe Hospital of Beijing, Beijing, Beijing, China
Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT02868801
- Locations
- 🇨🇳
Second Hospital Of Shanxi Medical University, Taiyuan, Shanxi, China
🇨🇳Xinjiang Uygur Autonomous Region Hospital OF TCM, Wulumuqi, Xinjiang, China
🇨🇳First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Effect of Rifampicin on the Pharmacokinetics of Apatinib
- Conditions
- Interventions
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02836821
- Locations
- 🇨🇳
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
Effect of Itraconazole on the Pharmacokinetics of Apatinib
- Conditions
- Interventions
- First Posted Date
- 2016-07-18
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02836171
- Locations
- 🇨🇳
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation
- First Posted Date
- 2016-07-15
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT02834936
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, Shanghai, China
🇨🇳HR-BLTN-II-NSCLC Investigational Site, Zhengzhou, China